Okay, so CML has drilling, exploring two good projects with EV just under $5m.
Management is quite conservative in expenditure, which is big plus for any junior explorer.
Enough cash for current quarter while further news expected from "Alotta" & "Lorraine".
Board hold 12% while Top20 52% (could have been changed now).
= CML looking attractive as a low risk/high reward play.
Summary of "Alotta Deposit" from 2018-19:
Current holes are just an extensions of previously known mineralized holes ,that has returned subs Ni, Cu in 2018. Hence, no assay to save money. Management really good in tight expenditure = Great strategy.
I believe there is more to come from Alotta in next few months time. Stake holders from previous pump are now out along with 1-2 major holders too.
Further new could greatly help CML to break through 5c resistance in MT-LT.
I bought few yesterday and topped up bit today with avg around market price.
ALL IMO. Please DYOR.
- Forums
- ASX - By Stock
- GCM
- Ann: DRILLING INTERSECTS WIDE MASSIVE SULPHIDE ZONES AT ALOTTA
Ann: DRILLING INTERSECTS WIDE MASSIVE SULPHIDE ZONES AT ALOTTA, page-115
-
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GCM (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $10.68M |
Open | High | Low | Value | Volume |
0.7¢ | 0.8¢ | 0.7¢ | $37.24K | 5.230M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 9206539 | 0.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.8¢ | 7861479 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 9206539 | 0.007 |
25 | 22927498 | 0.006 |
21 | 22005000 | 0.005 |
16 | 15014812 | 0.004 |
10 | 10626661 | 0.003 |
Price($) | Vol. | No. |
---|---|---|
0.008 | 7861479 | 11 |
0.009 | 6548859 | 7 |
0.010 | 7094581 | 7 |
0.011 | 5301844 | 9 |
0.012 | 4504995 | 8 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
GCM (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online